Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Home Topics

Law Firm Management

Features

Sales Speak: Top-Down Business Development Influence

Peter Johnson

Obstacles to developing a great business development culture come in all different shapes and sizes, and managing partners need to identify and deal with those challenges.

Features

Social Media Scene: Using Social Media

Mark W. Schaefer

It's been wonderful to observe the growth and progress in social media marketing over the years, but certain fields continue to lag behind. Financial. Pharmaceutical. And yes ' Legal.

Features

Five Truths About Law Firm Content Marketing

Keith Ecker

Content marketing is far from a turnkey solution, and it requires a tremendous amount of thought and attention to succeed.

Features

Slow Growth on Tap for 2014

Richard Lloyd

The painful decisions to cut staff and attorneys may now be a distant memory, at least for most firms, but there remain two distinct drags on Big Law businesses.

Features

New Associates and Your Firm

Bruce Elvin

This article is a guide for developing and improving new associate training in your firm.

Features

Data Analytics

Christopher Petrini-Poli & Scott Springer

Data analytics, the same data mining and interpretive analysis used for decades in other professions, is bringing change to the core business side of the legal profession.

Columns & Departments

At the Intersection: Notes on the New Year

Pamela Woldow

By this time next year, legal service delivery will have become less firm-driven, more client-driven, more collaborative and more complicated.

Moving the Sales Process Along (Frank Mims V.)

Allan Colman

Don't you just hate it when you know you have done everything correctly in the selling process and the customer is stalling? When the process is stalled several things are occurring with the prospect and with you.

Features

Meals and Entertainment Expenses

Jacob Weichholz

Meals and entertainment expenses are generally only 50% deductible, and provided the expenses are ordinary and necessary, have a business purpose and have proper documentation, there should be no issues surviving an IRS audit.

Features

Dancing on the Cliff Edge

William C. Cobb

In the last five years, we have heard increasing chatter about the failed business model of law firms, new technology that is erasing the need for lawyers and other information interpreters, and enhanced cognitive systems that mine and interpret data. Let's look at some examples of trends that are leading the way.

Need Help?

  1. Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
  2. Need other assistance? email Customer Service or call 1-877-256-2472.

MOST POPULAR STORIES

  • Surveys in Patent Infringement Litigation: The Next Frontier
    Most experienced intellectual property attorneys understand the significant role surveys play in trademark infringement and other Lanham Act cases, but relatively few are likely to have considered the use of such research in patent infringement matters. That could soon change in light of the recent admission of a survey into evidence in <i>Applera Corporation, et al. v. MJ Research, Inc., et al.</i>, No. 3:98cv1201 (D. Conn. Aug. 26, 2005). The survey evidence, which showed that 96% of the defendant's customers used its products to perform a patented process, was admitted as evidence in support of a claim of inducement to infringe. The court admitted the survey into evidence over various objections by the defendant, who had argued that the inducement claim could not be proven without the survey.
    Read More ›
  • In the Spotlight
    On May 9, 2003, the U.S. Attorney's Office for the District of Massachusetts announced that Bayer Corporation, the pharmaceutical manufacturer, had been sentenced and ordered to pay a criminal fine of $5,590,800 stemming from its earlier plea of guilty to violating the Federal Prescription Drug Marketing Act by failing to list with the FDA its drug product, Cipro, that was privately labeled for an HMO. Such listing is required under the federal Food, Drug &amp; Cosmetic Act. The Federal Prescription Drug Marketing Act, Pub. L. 100-293, enacted on April 22, 1988, as modified on August 26, 1992 by the Prescription Drug Amendments (PDA) Pub. L. 102-353, 106 Stat. 941, amended sections 301, 303, 503, and 801 of the Federal Food, Drug, and Cosmetic Act, codified at 21 U.S.C. '' 331, 333, 353, 381, to establish requirements for distributing prescription drug samples.
    Read More ›